India Cell Isolation Market (2026-2031)
The India Cell Isolation Market was valued at $57 Million in 2026 and projected to reach to $109.3 Million by 2031, representing a compound annual growth rate of CAGR 13.9%. India's cell isolation market is poised for substantial growth, driven by expanding healthcare infrastructure, rising investments in regenerative medicine research, and increasing adoption of cell therapy applications.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Cell Isolation Market Trends and Insights
- This accelerated expansion in India reflects increasing investments in regenerative medicine, cell therapy research, and diagnostic applications across the country's expanding healthcare infrastructure.
- India's growing biotechnology sector and rising adoption of advanced cell isolation technologies are driving demand among research institutions, hospitals, and diagnostic laboratories. The cell isolation market in India is supported by rising government initiatives in life sciences, increased funding for stem cell research, and growing collaborations between Indian institutions and global biotech companies.
- India's cost-competitive manufacturing capabilities and skilled workforce position the country as an emerging hub for cell isolation technology development and commercialization.
- Between 2026 and 2031, India is expected to witness heightened adoption of automated cell isolation systems and magnetic bead-based separation technologies across clinical and research settings..
Key Market Statistics
- CAGR (2026-2031) CAGR 13.9%
- Market Size, 2026 ~USD 57 Million
- Forecast, 2031 ~USD 109.3 Million
- Country India
India Cell Isolation Market Overview
Rapid Market Expansion :
India's cell isolation market is projected to grow from $57.0 million in 2026 to $109.3 million by 2031, driven by increasing adoption of advanced cell therapy technologies and regenerative medicine applications across the country.
Strong CAGR Performance :
With a CAGR of 13.9% through 2031, India's market growth outpaces the global average of 12.7%, reflecting accelerated investments in biotechnology infrastructure and rising demand for cell-based therapeutics.
Healthcare Infrastructure Development :
Expanding diagnostic centers, research institutions, and biotech hubs across major Indian cities are creating robust demand for cell isolation technologies and supporting clinical and research applications.
Regenerative Medicine & Cell Therapy Focus :
Increasing government support, private sector investments, and clinical trials in regenerative medicine and cell therapy are positioning India as a key hub for cell isolation technology adoption and innovation.
India Cell Isolation Market Dynamics
- The country's growing biotechnology sector, coupled with government initiatives supporting medical innovation, creates favorable conditions for market expansion.
- Diagnostic applications and research institutions are increasingly incorporating advanced cell isolation technologies, supporting market penetration across tier-1 and tier-2 cities. The forecast period through 2031 will likely see accelerated adoption as India strengthens its position in global cell therapy development and clinical applications.
- Enhanced regulatory frameworks, increased funding for biomedical research, and growing collaborations between academic institutions and private enterprises will further propel market growth, making India an increasingly attractive market for cell isolation technology providers and investors..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- India's cell isolation market is valued at $57.0 million in 2026 and is forecast to reach $109.3 million by 2031, growing at a 13.9% CAGR.
- India's expanding biotechnology sector and government support for life sciences research are primary drivers of market growth.
- Rising adoption of automated and magnetic bead-based cell isolation technologies in India's research and clinical institutions is accelerating market expansion.
- India's cost-competitive manufacturing and skilled workforce position the country as an emerging global hub for cell isolation technology development.
Cell Isolation Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SURFACE MARKER-BASED CELL ISOLATION (Technique) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 12.7% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.38 (2026) |
| Revenue Forecast (Billions) | ~USD 7.97 (2031) |
| Segments Covered | Product, Type, Cell Type, Cell Source, Technique |
India Cell Isolation Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Beads
- Differentiated Cells
- Disposables
- Media & Sera
- Reagents & Kits
- Stem Cells
By Cell Type
- Animal Cells
- Human Cells
By Cell Source
- Adipose Tissue
- Blood & Blood-Derived Samples
- Bone Marrow
- Cord Blood/ Embryonic Stem Cells
- Other Cell Sources
By Technique
- Centrifugation-Based Cell Isolation
- Filtration-Based Cell Isolation
- Microfluidics & Label-Free Cell Isolation
- Surface Marker-Based Cell Isolation
INDIA: CELL ISOLATION MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 36.4 | 38.8 | 42 | 46.4 | 52.5 | 60.8 | 72.2 | 87.5 | 15.8 |
| HOSPITALS & DIAGNOSTIC LABORATORIES | 15.9 | 16.8 | 18 | 19.8 | 22.3 | 25.6 | 30.2 | 36.4 | 15.1 |
| OTHER END USERS | 11.8 | 12.4 | 13.2 | 14.5 | 16.2 | 18.5 | 21.7 | 26 | 14.4 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 51.3 | 53.7 | 57 | 61.9 | 69 | 78.6 | 91.7 | 109.3 | 13.9 |
| TOTAL | 115.4 | 121.7 | 130.2 | 142.5 | 159.9 | 183.6 | 215.7 | 259.2 | 14.8 |
Target Audience
- Biotech & Cell Therapy Companies : Organizations developing cell isolation technologies and therapies need India-specific market data to assess market potential, plan product launches, and identify partnership opportunities in this high-growth region.
- Healthcare Investors & PE Firms : Investment professionals require detailed India market analysis to evaluate funding opportunities, assess portfolio company growth potential, and make informed decisions on biotech and regenerative medicine investments.
- Diagnostic & Research Institutions : Academic centers and diagnostic labs in India need market intelligence to justify technology investments, secure funding, and understand competitive positioning within the expanding cell isolation landscape.
- Medical Device Manufacturers : Equipment and device suppliers require India-specific market forecasts to develop localized product strategies, establish distribution networks, and capitalize on growing demand from healthcare facilities.
- Government & Policy Bodies : Healthcare regulators and policy makers need comprehensive market data to inform biotech sector development initiatives, funding allocations, and regulatory frameworks supporting cell therapy innovation in India.
Key Companies in the India Cell Isolation Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| CEPHEID INC. | United States | Private Company | GeneXpert instruments and Xpert test cartridges,SmartCycler system and reagents,Custom and collaborative programs (USPS BDS, TB, Ebola, new molecular tests), |
| MAXCYTE, INC | United States | Public Company | ExPERT STx and GTx flow electroporation instruments,ExPERT ATx and VLx instruments,Disposable processing assemblies (PAs), |
| GENERAL ELECTRIC | United States | Public Company | Commercial Engines & Services,Defense & Propulsion Technologies, |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and single-use),Life Sciences tools and genomics,Diagnostics, |
| MERCK KGAA | Germany | Public Company | Life Science (reagents, consumables, bioprocessing, CDMO/testing),Healthcare (oncology, neurology, fertility, rare diseases, cardiovascular, metabolic),Electronics (semiconductor and display materials, specialty gases, delivery equipment), |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (syringes, needles, catheters, sharps, vascular care),Connected Care (infusion, dispensing, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery, pharma solutions), |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets, |
| SARTORIUS AG | Germany | Public Company | Bioprocess solutions (bioreactors, cell culture, fluid management, process filtration),Analytical instruments and process analytics,Lab products and services (filtration, water systems, weighing, pipettes, microbiological testing), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics,Life Science Research and Bioprocess, |
| QIAGEN | Netherlands | Public Company | Sample technologies (nucleic acid purification & stabilization),Molecular diagnostics assays (immune response, oncology, SRH, viral load),PCR & dPCR instruments and reagents, |
| REVVITY | United States | Public Company | Diagnostics instruments and automation platforms,Diagnostics reagents, assays, and kits,Life science research tools and genomic workflow solutions, |
| CORNING INCORPORATED | United States | Public Company | Optical Communications (fiber, cable, hardware, components),Display Glass Substrates (LCD, OLED),Specialty Materials (mobile, semiconductor optics, defense, radiation shielding, sunglasses), |
| LONZA | Switzerland | Public Company | Integrated Biologics (mammalian and drug product platforms),Advanced Synthesis (small molecules, HPAPIs, ADCs and bioconjugates),Specialized Modalities (cell & gene, microbial, bioscience, mRNA), |
| BIO-TECHNE | United States | Public Company | Protein Sciences (reagents and proteomic tools),Diagnostics (controls, calibrators, assays, process controls),Spatial Biology and Genomics, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
CEPHEID INC.
Cepheid Inc. is a United States-based private company founded in 1996 with 1,700 employees. The company develops molecular diagnostics and point-of-care testing solutions.
MAXCYTE, INC
MaxCyte, Inc. is a publicly traded United States company founded in 1998 with 91 employees. The company develops cell engineering technologies and platforms.
GENERAL ELECTRIC
General Electric is a publicly traded United States conglomerate founded in 1892 with 57,000 employees. The company operates across multiple industrial and technology sectors.
GE HEALTHCARE
GE Healthcare is a publicly traded United States company established in 2022 with 54,000 employees. The company provides medical imaging, diagnostics, and healthcare IT solutions.
DANAHER CORPORATION
Danaher Corporation is a publicly traded United States company founded in 1969 with 59,000 employees. The company operates a diversified portfolio of businesses in life sciences, diagnostics, and environmental solutions.
MERCK KGAA
Merck KGaA is a publicly traded German company founded in 1668 with 59,077 employees. The company operates in pharmaceuticals, life sciences, and performance materials.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a publicly traded United States company founded in 1956 with 125,000 employees. The company provides laboratory equipment, reagents, and services for research and diagnostics.
BECTON, DICKINSON AND COMPANY
Becton, Dickinson and Company is a publicly traded United States company founded in 1897 with 72,000 employees. The company manufactures medical devices, laboratory equipment, and diagnostic products.
AGILENT TECHNOLOGIES, INC.
Agilent Technologies, Inc. is a publicly traded United States company founded in 1999 with 18,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.
SARTORIUS AG
Sartorius AG is a publicly traded German company founded in 1870 with 14,242 employees. The company manufactures laboratory and bioprocess equipment for pharmaceutical and biotechnology industries.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a publicly traded United States company founded in 1952 with 7,450 employees. The company develops and manufactures life science research and clinical diagnostics products.
QIAGEN
QIAGEN is a publicly traded Netherlands-based company founded in 1984 with 5,500 employees. The company provides molecular diagnostics, sample preparation, and bioinformatics solutions.
REVVITY
Revvity is a publicly traded United States company founded in 1937 with 11,000 employees. The company provides analytical instruments, software, and services for life sciences research and diagnostics.
CORNING INCORPORATED
Corning Incorporated is a publicly traded United States company founded in 1851 with 67,200 employees. The company manufactures specialty glass, ceramics, and laboratory products.
LONZA
Lonza is a publicly traded Swiss company founded in 1897 with 20,000 employees. The company provides contract manufacturing and life science solutions for pharmaceuticals and biotechnology.
BIO-TECHNE
Bio-Techne is a publicly traded United States company founded in 1976 with 3,100 employees. The company develops and manufactures proteins, antibodies, and reagents for life sciences research.
TERUMO CORPORATION
Terumo Corporation is a publicly traded Japanese company founded in 1921 with 30,591 employees. The company manufactures medical devices and blood management solutions.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for India ($57.0M in 2026, $109.3M in 2031) with verified CAGR of 13.9%, enabling accurate business planning and investment decisions specific to the Indian market.
- Competitive Positioning Intelligence : Understand India's market dynamics relative to global trends (12.7% global CAGR) to identify competitive advantages, market gaps, and opportunities for differentiation in the rapidly expanding Indian cell isolation sector.
- Strategic Investment Guidance : Access actionable insights on India's regenerative medicine and cell therapy landscape to guide capital allocation, partnership strategies, and market entry decisions for healthcare and biotech organizations.
- Regulatory & Infrastructure Insights : Gain detailed understanding of India's expanding healthcare infrastructure, diagnostic centers, and research institutions driving cell isolation adoption, supporting informed expansion and localization strategies.
- Forecast-Driven Planning : Leverage comprehensive 2026-2031 projections for India to develop long-term product development roadmaps, sales forecasts, and resource allocation strategies aligned with market growth trajectories.
Frequently asked questions
What is the current size of India's cell isolation market?
India's cell isolation market is valued at $57.0 million in 2026 and is projected to grow to $109.3 million by 2031.
What is the growth rate of India's cell isolation market?
India's cell isolation market is growing at a compound annual growth rate (CAGR) of 13.9% from 2026 to 2031.
What are the main drivers of growth in India's cell isolation market?
Key drivers include increasing investments in regenerative medicine, government support for stem cell research, rising adoption of advanced technologies, and growing collaborations between Indian and global biotech companies.
Which technologies are gaining adoption in India's cell isolation market?
Automated cell isolation systems and magnetic bead-based separation technologies are experiencing heightened adoption across India's research institutions and clinical settings.
Why is India becoming a hub for cell isolation technology?
India's cost-competitive manufacturing capabilities, skilled workforce, expanding biotechnology sector, and government initiatives in life sciences position it as an emerging global hub for cell isolation technology development and commercialization.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect information for analysis of the global cell isolation market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was triangulated with primary research inputs to determine the final market size.
Secondary Research
Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the cell isolation market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), Stem Cell Society Singapore (SCSS), International Society for Advancement of Cytometry (ISAC), American Filtration and Separations Society (AFS), Food and Drug Administration (FDA), American Society for Cell Biology (ASC8), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT), American Society for Gene and Cell Therapy (ASGCT), Pharmaceutical Research and Manufacturers of America (PhRMA), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), and the Alliance for Regenerative Medicine (ARM). Secondary data were collected and analyzed to determine the overall size of the global cell isolation market, which was subsequently validated through primary research. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The top-down and bottom-up approaches were used to estimate & validate the total size of the cell isolation market. These methods were also used extensively to estimate the size of various market segments.
Cell Isolation Market/Cell Separation Market : Top-Down and Bottom-Up Approach
Data Triangulation
After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.
Market Definition
Cell isolation is the process of separating specific cells from a given sample. It is a tool in biological research that enables the isolation of a single cell type from heterogeneous cell populations without contamination by other cell types. This process is widely used for the isolation of biomolecules to produce vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.
Key Stakeholders
- Pharmaceutical & biotechnology companies
- Contract research organizations (CROs)
- Life science companies
- Academic & research institutes
- Private research institutes
- Venture capitalists & investors
- Hospitals and diagnostic laboratories
- Market research & consulting firms
- Medical institutions & universities
Report Objectives
- To define, describe, and forecast the cell isolation market based on product, cell type, cell source, technique, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall cell isolation market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players in the cell isolation market and comprehensively analyze their core competencies and market rankings
- To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the cell isolation market
- To benchmark players within the cell isolation market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy
Customization Options :
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:
Geographical Analysis
- Further breakdown of the Rest of Europe Cell Isolation Market, by country
- Further breakdown of the Rest of Asia Pacific Cell Isolation Market, by country
- Further breakdown of the Rest of Latin America Cell Isolation Market, by country
- Further breakdown of the Rest of Middle East Cell Isolation Market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Get the Full Cell Isolation Market Report
Full forecast, segment splits, and company analysis for all Cell Isolation Market.
- US Cell Isolation Market
- Canada Cell Isolation Market
- Germany Cell Isolation Market
- UK Cell Isolation Market
- France Cell Isolation Market
- Italy Cell Isolation Market
- Spain Cell Isolation Market
- China Cell Isolation Market
- Japan Cell Isolation Market
- Australia Cell Isolation Market
- South Korea Cell Isolation Market
- Brazil Cell Isolation Market
- Mexico Cell Isolation Market
- Saudi Arabia Cell Isolation Market
- UAE Cell Isolation Market
- Rest Of Europe Cell Isolation Market
- Rest Of Asia Pacific Cell Isolation Market
- Rest Of Latin America Cell Isolation Market
- Rest Of GCC Countries Cell Isolation Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report